Detalhe da pesquisa
1.
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring.
J Oncol Pharm Pract
; : 10781552221104422, 2022 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35673764
2.
Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
Eur J Haematol
; 106(4): 584-588, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459429
3.
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(2): 262-271, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610237
4.
Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 25(12): 2522-2526, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31525493
5.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716453
6.
Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma.
Transpl Infect Dis
; 21(4): e13114, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102556
7.
Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation.
J Clin Apher
; 34(6): 638-645, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381194
8.
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1029-1034, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369800
9.
Validation of the role of corrected DLCO in predicting outcomes post autologous hematopoietic cell transplant for multiple myeloma.
Eur J Haematol
; 110(6): 780-783, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949569
10.
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.
J Clin Apher
; 33(3): 303-309, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29134688
11.
Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study.
Biol Blood Marrow Transplant
; 23(9): 1567-1572, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533058
12.
Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 23(5): 776-781, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108271
13.
Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma.
Am J Hematol
; 92(10): 989-996, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612386
14.
The association of histologic grade with acute graft-versus-host disease response and outcomes.
Am J Hematol
; 92(7): 683-688, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28376566
15.
Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 22(6): 1141-1144, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26995694
16.
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(9): 1588-1595, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27343718
17.
Is rituximab sub-optimally dosed in indolent B cell lymphoma?
Br J Haematol
; 174(5): 721-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27136331
18.
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
Br J Haematol
; 175(2): 275-280, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27443247
19.
Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.
Br J Haematol
; 173(3): 404-12, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26953041
20.
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.
Br J Haematol
; 168(6): 811-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25404094